These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6312379)

  • 1. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
    Soranzo ML; Capra E; Angela GC; Eandi M; Salassa B; Lollini P; Musso E; Pizzo L; Spezia C; Di Nola F
    Minerva Med; 1983 Sep; 74(36):2093-102. PubMed ID: 6312379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
    Soranzo ML; Capra E; Eandi M; Angela GC; Musso E; Bendiscioli L; Salassa B; Braida M; Lollini P; Pizzo L; Cignolo G; Spezia C; Andreoni G; Bramato C; di Nola F
    Minerva Med; 1983 Jun; 74(27):1639-50. PubMed ID: 6343925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
    Rothwell DL; Bremner DA; Taylor KM
    N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE; Neu HC
    Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative experimental antibacterial activity of ceftriaxone (Ro 13-9904).
    Böhni E
    Chemioterapia; 1984 Feb; 3(1):25-32. PubMed ID: 6100173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of acute respiratory infections in childhood with a new cephalosporin, ceftriaxone].
    Berni Canani M; Leone L; Della Rotonda G; Palazzi A
    Pediatr Med Chir; 1984; 6(2):277-80. PubMed ID: 6099551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
    Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Piperacillin: microbiological and clinical studies].
    Soranzo ML; Capra E; Angela GC; Salassa B; Bramato C; Andreoni G; Pizzo L; Musso E; Spezia C; Cignolo G; Di Nola F
    Minerva Med; 1983 Jul; 74(28-29):1765-70. PubMed ID: 6223239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of a new cephalosporin ceftriaxone (Ro 13-9904) in sepsis and other infectious forms of particular severity].
    Calonghi GF; Vezzani F
    G Ital Chemioter; 1981; 28(1-2):55-9. PubMed ID: 6290304
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children].
    De Marco A; Manca B
    Ann Osp Maria Vittoria Torino; 1983; 26(1-6):91-6. PubMed ID: 6093666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections.
    Joos B; Luethy R; Muehlen E; Siegenthaler W
    Am J Med; 1984 Oct; 77(4C):59-62. PubMed ID: 6093521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ceftriaxone (Rocéphine) in major African infectious pathology. Results at the Niamey Hospital (Niger) ].
    Rey JL; Konarjevski R; Madras R; Ousseini A; Félix H
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):513-6. PubMed ID: 6289228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings.
    Eron LJ; Goldenberg RI; Poretz DM
    Am J Surg; 1984 Oct; 148(4A):1-4. PubMed ID: 6091473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.